Phase 1-2a dose-ranging study of TLK199 tablets in myelodysplastic syndrome (MDS).
Phase of Trial: Phase I/II
Latest Information Update: 30 May 2012
At a glance
- Drugs Ezatiostat (Primary)
- Indications Myelodysplastic syndromes
- Focus Adverse reactions; Therapeutic Use
- Sponsors Telik
- 14 Jan 2008 Status change from recruiting to completed.
- 06 Dec 2007 Results will be presented at "Myelodysplastic Syndromes: Clinical Studies, Including Transplantation".
- 10 Feb 2006 New trial record.